The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes

Tsunehiko Ikeda,1 Kimitoshi Nakamura,2 Hidehiro Oku,1 Seita Morishita,1 Masanori Fukumoto,1 Hiroyuki Suzuki,1 Teruyo Kida,1 Taeko Horie,1 Tetsuya Sugiyama,3 Shinji Takai4 1Department of Ophthalmology, Osaka Medical College, Takatsuki City, Osaka, Japan; 2Nakamura Eye Clinic, Nagano, Japan; 3Nakano...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ikeda T, Nakamura K, Oku H, Morishita S, Fukumoto M, Suzuki H, Kida T, Horie T, Sugiyama T, Takai S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/ab621e7f94464b7c80f26fff8945049a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab621e7f94464b7c80f26fff8945049a
record_format dspace
spelling oai:doaj.org-article:ab621e7f94464b7c80f26fff8945049a2021-12-02T00:29:09ZThe role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes1177-5483https://doaj.org/article/ab621e7f94464b7c80f26fff8945049a2015-06-01T00:00:00Zhttp://www.dovepress.com/the-role-of-tryptase-and-anti-type-ii-collagen-antibodies-in-the-patho-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Tsunehiko Ikeda,1 Kimitoshi Nakamura,2 Hidehiro Oku,1 Seita Morishita,1 Masanori Fukumoto,1 Hiroyuki Suzuki,1 Teruyo Kida,1 Taeko Horie,1 Tetsuya Sugiyama,3 Shinji Takai4 1Department of Ophthalmology, Osaka Medical College, Takatsuki City, Osaka, Japan; 2Nakamura Eye Clinic, Nagano, Japan; 3Nakano Eye Clinic, Kyoto, Japan; 4Department of Pharmacology, Osaka Medical College, Takatsuki City, Osaka, Japan Purpose: To investigate the pathogenesis of idiopathic epiretinal membrane (ERM) from a biochemical perspective, the relationships between ERM and tryptase activity, a serine protease, and the levels of anti-type II collagen (anti-IIC) antibodies in the serum.Patients and methods: Vitreous samples for measurement of tryptase activity were obtained from 54 eyes of 54 patients who underwent a vitrectomy for vitreoretinal disease, ie, 14 eyes of 14 patients with idiopathic macular hole, 14 eyes of 14 patients with proliferative diabetic retinopathy (PDR), 13 eyes of 13 patients with ERM, and 13 eyes of 13 patients with rhegmatogenous retinal detachment (RRD). Tryptase activity was measured by spectrophotometry. Anti-IIC antibodies were measured in the serum obtained from 17 patients with ERM, eight patients who underwent cataract surgery, 12 patients with PDR, and nine patients with RRD. In these 46 patients, the anti-IIC antibodies were measured using a Human/Monkey Anti-Type I and Type II Collagen IgG Assay Kit.Results: Vitreal tryptase activity (mean ± standard deviation [SD]) in macular hole, PDR, ERM, and RRD was 0.0146±0.0053, 0.0018±0.0018, 0.0166±0.0046, and 0.0117±0.0029 mU/mg protein, respectively. Vitreal tryptase activity was significantly higher in macular hole and ERM than in PDR and RRD (P<0.05, Fisher’s protected least significant difference). The serum levels of anti-IIC immunoglobulin G (IgG) antibody (mean ± SD) in ERM, cataract surgery, PDR, and RRD were 58.222±30.986, 34.890±18.165, 55.760±26.008, and 35.453±12.769 units/mL, respectively. The serum levels of anti-IIC IgG antibody were significantly higher in ERM and PDR than in cataract surgery and RRD (P<0.05, Fisher’s protected least significant difference, two-sided).Conclusion: In the pathogenesis of ERM, increased vitreal tryptase activity may be involved in tissue fibrosis, and elevated serum anti-IIC antibodies may lead to an immune response at the vitreoretinal interface, thus resulting in membrane formation. Keywords: idiopathic epiretinal membranes, tryptase, anti-type II collagen antibodies, vitrectomy, mast cellsIkeda TNakamura KOku HMorishita SFukumoto MSuzuki HKida THorie TSugiyama TTakai SDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1181-1186 (2015)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Ikeda T
Nakamura K
Oku H
Morishita S
Fukumoto M
Suzuki H
Kida T
Horie T
Sugiyama T
Takai S
The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
description Tsunehiko Ikeda,1 Kimitoshi Nakamura,2 Hidehiro Oku,1 Seita Morishita,1 Masanori Fukumoto,1 Hiroyuki Suzuki,1 Teruyo Kida,1 Taeko Horie,1 Tetsuya Sugiyama,3 Shinji Takai4 1Department of Ophthalmology, Osaka Medical College, Takatsuki City, Osaka, Japan; 2Nakamura Eye Clinic, Nagano, Japan; 3Nakano Eye Clinic, Kyoto, Japan; 4Department of Pharmacology, Osaka Medical College, Takatsuki City, Osaka, Japan Purpose: To investigate the pathogenesis of idiopathic epiretinal membrane (ERM) from a biochemical perspective, the relationships between ERM and tryptase activity, a serine protease, and the levels of anti-type II collagen (anti-IIC) antibodies in the serum.Patients and methods: Vitreous samples for measurement of tryptase activity were obtained from 54 eyes of 54 patients who underwent a vitrectomy for vitreoretinal disease, ie, 14 eyes of 14 patients with idiopathic macular hole, 14 eyes of 14 patients with proliferative diabetic retinopathy (PDR), 13 eyes of 13 patients with ERM, and 13 eyes of 13 patients with rhegmatogenous retinal detachment (RRD). Tryptase activity was measured by spectrophotometry. Anti-IIC antibodies were measured in the serum obtained from 17 patients with ERM, eight patients who underwent cataract surgery, 12 patients with PDR, and nine patients with RRD. In these 46 patients, the anti-IIC antibodies were measured using a Human/Monkey Anti-Type I and Type II Collagen IgG Assay Kit.Results: Vitreal tryptase activity (mean ± standard deviation [SD]) in macular hole, PDR, ERM, and RRD was 0.0146±0.0053, 0.0018±0.0018, 0.0166±0.0046, and 0.0117±0.0029 mU/mg protein, respectively. Vitreal tryptase activity was significantly higher in macular hole and ERM than in PDR and RRD (P<0.05, Fisher’s protected least significant difference). The serum levels of anti-IIC immunoglobulin G (IgG) antibody (mean ± SD) in ERM, cataract surgery, PDR, and RRD were 58.222±30.986, 34.890±18.165, 55.760±26.008, and 35.453±12.769 units/mL, respectively. The serum levels of anti-IIC IgG antibody were significantly higher in ERM and PDR than in cataract surgery and RRD (P<0.05, Fisher’s protected least significant difference, two-sided).Conclusion: In the pathogenesis of ERM, increased vitreal tryptase activity may be involved in tissue fibrosis, and elevated serum anti-IIC antibodies may lead to an immune response at the vitreoretinal interface, thus resulting in membrane formation. Keywords: idiopathic epiretinal membranes, tryptase, anti-type II collagen antibodies, vitrectomy, mast cells
format article
author Ikeda T
Nakamura K
Oku H
Morishita S
Fukumoto M
Suzuki H
Kida T
Horie T
Sugiyama T
Takai S
author_facet Ikeda T
Nakamura K
Oku H
Morishita S
Fukumoto M
Suzuki H
Kida T
Horie T
Sugiyama T
Takai S
author_sort Ikeda T
title The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
title_short The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
title_full The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
title_fullStr The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
title_full_unstemmed The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
title_sort role of tryptase and anti-type ii collagen antibodies in the pathogenesis of idiopathic epiretinal membranes
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/ab621e7f94464b7c80f26fff8945049a
work_keys_str_mv AT ikedat theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT nakamurak theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT okuh theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT morishitas theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT fukumotom theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT suzukih theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT kidat theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT horiet theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT sugiyamat theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT takais theroleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT ikedat roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT nakamurak roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT okuh roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT morishitas roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT fukumotom roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT suzukih roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT kidat roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT horiet roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT sugiyamat roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
AT takais roleoftryptaseandantitypeiicollagenantibodiesinthepathogenesisofidiopathicepiretinalmembranes
_version_ 1718403698429788160